Do Honey Packs Work for Women?

While honey packs have traditionally been marketed to men, brands increasingly target women with products claiming to enhance libido, arousal, sensation, and lubrication. Some are gender-specific formulations; others are the same male-targeted products with revised marketing. The female honey pack market is growing rapidly, driven by social media promotion and word-of-mouth.

However, the evidence base for these products in women is even thinner than for men. Most herbal ingredient research has been conducted in male subjects, and the undeclared pharmaceutical compounds found by the FDA were developed specifically for male erectile dysfunction.

If a honey pack contains undeclared sildenafil or tadalafil, these compounds have physiological effects in women — but different from men. PDE5 inhibitors increase blood flow to genital tissue in both sexes. In women, this can theoretically enhance clitoral engorgement and vaginal lubrication. However, clinical trials of sildenafil in women have produced mixed and mostly disappointing results for subjective arousal and satisfaction.

The disconnect between increased genital blood flow and subjective arousal is well-documented in female sexual response research. Physical arousal and psychological desire are less tightly coupled in women than in men. Increased blood flow alone may not translate to an improved experience. Meanwhile, the side effects — headache, flushing, dizziness, blood pressure changes — are similar to those experienced by men.

Maca root has the most evidence for female use, with a small number of studies suggesting modest improvement in sexual desire in postmenopausal women. Tongkat Ali has been studied primarily in men; data in women is very limited. Royal jelly has been investigated for menopausal symptoms with some preliminary positive results, but not specifically for sexual enhancement.

The honest assessment is that no herbal ingredient commonly found in honey packs has strong, replicated clinical evidence for meaningful sexual enhancement in women. The effects women report may be a combination of placebo response, mild herbal activity, and (in adulterated products) pharmaceutical vasodilation.

Women face certain unique risks with honey pack use:

• Pregnancy risk: Undeclared pharmaceutical ingredients could harm fetal development. Women who are or could become pregnant should avoid honey packs entirely.
• Hormonal contraception interactions: Some herbal ingredients may theoretically affect hormone metabolism, though evidence is limited.
• Blood pressure effects: Women taking antihypertensives face the same interaction risks as men if the product contains hidden PDE5 inhibitors.
• Unknown dose calibration: The hidden pharmaceutical doses were designed for male anatomy and body weight. The per-kilogram dose for a smaller woman could be proportionally much higher.

Women seeking to address sexual function concerns have several evidence-based options worth exploring with a healthcare provider: FDA-approved treatments for hypoactive sexual desire disorder, hormone therapy for menopause-related changes, pelvic floor physical therapy, and sex therapy or counseling. These approaches are regulated, studied, and tailored to female physiology. Our safety resource center has more information on making informed supplement decisions.